Long-acting injectables are transforming schizophrenia treatment by ensuring medication adherence and reducing relapse rates.

“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...

The incidence of cannabis use disorder associated with schizophrenia almost tripled among Canadian teenagers and adults after ...

If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...

“I think the concern is that daily cannabis use has really increased in the last 15 years and at the same time the potency of ...

Cannabis is gaining widespread appeal and a growing number of U.S. states are approving medical marijuana. A large study ...

4 — linked rising cases of psychosis and schizophrenia in Canada to CUD since the country legalized recreational ... CUD ...

Two new Canadian studies are the largest to date looking at death rates and psychosis associated with cannabis use disorder.

The proportion of new schizophrenia cases linked to cannabis use has nearly tripled in almost two decades, increasing ...

Risk factors for psychosis in youth include sexual minority status (SMS), with notable associations between SMS and adverse childhood experiences.

Researchers believe a combination of factors set off chemical and structural changes in the brain. Ultimately, these changes lead to schizophrenia. Those same factors may influence when or how ...

All three conditions are linked to cerebral small vessel disease, a condition associated with aging and accumulation of vascular risk factors." Tamara N. Kimball, M.D., postdoctoral research ...